IMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congress
23. Oktober 2023 08:30 ET
|
Imunon, Inc.
Highlights advantages of IMUNON’s PlaCCine modality over current commercial vaccines LAWRENCEVILLE, N.J., Oct. 23, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage...